Evidence map›Paper›PMID 39582930›Full record

ArticleInternational journal of pharmaceutics: X2024

A hybrid system of mixture models for the prediction of particle size and shape, density, and flowability of pharmaceutical powder blends.

Mohammad Salehian, Jonathan Moores, Jonathan Goldie, Isra' Ibrahim, Carlota Mendez Torrecillas, Ishwari Wale, Faisal Abbas, Natalie Maclean, John Robertson, Alastair Florence and 1 more

Abstract read
In one paragraph

Article in International journal of pharmaceutics: X, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mohammad SalehianDigital Medicines Manufacturing (DM) Research Centre, Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Jonathan MooresCentre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Jonathan GoldieDigital Medicines Manufacturing (DM) Research Centre, Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Isra' IbrahimCentre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Carlota Mendez TorrecillasCentre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Ishwari WaleCentre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Faisal AbbasDigital Medicines Manufacturing (DM) Research Centre, Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Natalie MacleanCentre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
John RobertsonCentre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Alastair FlorenceDigital Medicines Manufacturing (DM) Research Centre, Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.
Daniel MarklDigital Medicines Manufacturing (DM) Research Centre, Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC), Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a system of hybrid models that combine both mechanistic and data-driven approaches to predict physical powder blend properties from their raw component properties. Mechanistic, probabilistic models were developed to predict the particle size and shape, represented by aspect ratio, distributions of pharmaceutical blends using those of the raw components. Additionally, the accuracy of existing mixture rules for predicting the blend's true density and bulk density was assessed. Two data-driven models were developed to estimate the mixture's tapped density and flowability (represented by the flow function coefficient, FFC) using data from 86 mixtures, which utilized the principal components of predicted particle size and shape distributions in combination with the true density, and bulk density as input data, saving time and material by removing the need for resource-intensive shear testing for raw components. A model-based uncertainty quantification technique was designed to analyse the precision of model-predicted FFCs. The proposed particle size and shape mixture models outperformed the existing approach (weighted average of distribution percentiles) in terms of prediction accuracy while providing insights into the full distribution of the mixture. The presented hybrid system of models accurately predicts the mixture properties of different formulations and components with often

Indexed as

Bulk densityComputational modelFlowabilityParticle shapeParticle sizePharmaceutical mixturesTapped densityTrue density

Identifiers

PMID39582930
PMCPMC11584682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.